Notable Analyst Rating Changes 10/22: FFIV, FCX, LMT, MOT, NVLS Upgraded; CHK, SAP, STJ, NTRS, FIS downgraded
UPGRADES:
UBS upgrades F5 Networks (Nasdaq: FFIV) from Sell to Neutral. Price target increased to $47 from $29.
Deutsche Bank upgrades Freeport-McMoRan (NYSE: FCX) to Buy. Price target increased from $72 to $100. Click Here for more color.
Buckingham Research upgrades shares of Lockheed Martin (NYSE: LMT) from Accumulate to Strong Buy.
Thomas Weisel upgrades Motorola (NYSE: MOT) from Marketweight to Overweight. Price target increased from $7 to $11.
Deutsche Bank upgrades Novellus Systems (Nasdaq: NVLS) to Hold. Price target increased from $13 to $18. For more color, Click Here.
For daily real-time Upgrades go to http://www.streetinsider.com/Upgrades
DOWNGRADES:
Chesapeake Energy (NYSE: CHK) gets downgraded by UBS. The firm lowered its rating on Chesapeake from Buy to Neutral.
Bank of America downgrades SAP AG (NYSE: SAP) from Buy to Neutral.
FTN Equity downgrades St. Jude Medical (NYSE: STJ) from Buy to Neutral.
FTN Equity downgrades Northern Trust (Nasdaq: NTRS) from Buy to Neutral. Price target lowered from $65 to $55.
Duncan-Williams downgrades Fidelity National Information Services (NYSE: FIS) from Strong Buy to Buy. Price Target $28. Click Here for more color.
For daily real-time Downgrades go to http://www.streetinsider.com/Downgrades
NEW COVERAGE:
Pali Research initiates coverage on Tenet Healthcare (NYSE: THC) with a Buy. Price target $8.25. For more color, Click Here.
Jesup & Lamont initiates coverage on Limited Brands (NYSE: LTD) with a Hold.
Pali Research initiates coverage on Health Management Associates (NYSE: HMA) with a Neutral. Click Here for more color.
For daily real-time New Coverage go to http://www.streetinsider.com/New+Coverage
Related Categories
Special ReportsStocks Mentioned
Related Entities
- Deutsche Bank
- UBS
- Banc of America
- Pali Research
- Jesup & Lamont
- Thomas Weisel Partners Group
- Buckingham Research
- Notable Analyst Rating Changes
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
